# Fathom Holdings Inc.: financial statements, quarterly

FTHM · Nasdaq · CIK 1753162 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fthm.md) · [Financials](/companies/fthm/financials.md) · [Filings](/companies/fthm/filings.md) · [Insiders](/companies/fthm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fthm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [93.5](/filings/0001628280-24-046829.md) | [74.1 d](/filings/0001628280-25-015336.md) | [70.5](/filings/0001628280-25-025081.md) | [89.2](/filings/0001628280-25-039906.md) | [83.7](/filings/0001628280-25-051342.md) | [91.7 d](/filings/0001628280-26-022057.md) | [93.1](/filings/0001628280-26-048455.md) | [121](/filings/0001628280-26-056741.md) | [115](/filings/0001628280-25-051342.md) | [90.6 d](/filings/0001628280-26-022057.md) | [86.4](/filings/0001628280-26-048455.md) | [115](/filings/0001628280-26-056741.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [0.1](/filings/0001628280-23-038349.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(5.4)](/filings/0001628280-24-046829.md) | [(8.1) d](/filings/0001628280-25-015336.md) | [(5.7)](/filings/0001628280-25-025081.md) | [(3.6)](/filings/0001628280-25-039906.md) | [(7.8)](/filings/0001628280-25-051342.md) | [(9.0) d](/filings/0001628280-26-022057.md) | [(4.4)](/filings/0001628280-26-048455.md) | [(2.4)](/filings/0001628280-26-056741.md) | [(4.0)](/filings/0001628280-25-051342.md) | [(4.7) d](/filings/0001628280-26-022057.md) | [(7.6)](/filings/0001628280-26-048455.md) | [(4.3)](/filings/0001628280-26-056741.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.0](/filings/0001628280-24-046829.md) | [0.1 d](/filings/0001628280-25-015336.md) | [0.0](/filings/0001628280-25-025081.md) | [(0.0)](/filings/0001628280-25-039906.md) | [0.0](/filings/0001628280-25-051342.md) | [(1.1) d](/filings/0001628280-26-022057.md) | [0.0](/filings/0001628280-26-048455.md) | [0.1](/filings/0001628280-26-056741.md) | [0.0](/filings/0001628280-25-051342.md) | [(0.0) d](/filings/0001628280-26-022057.md) | [0.0](/filings/0001628280-26-048455.md) | [0.0](/filings/0001628280-26-056741.md) |
| Net income | $m | [(5.5)](/filings/0001628280-24-046829.md) | [(8.4) d](/filings/0001628280-25-015336.md) | [(5.9)](/filings/0001628280-25-025081.md) | [(1.3)](/filings/0001628280-25-039906.md) | [(8.1)](/filings/0001628280-25-051342.md) | [(6.2) d](/filings/0001628280-26-022057.md) | [(5.6)](/filings/0001628280-26-048455.md) | [(3.6)](/filings/0001628280-26-056741.md) | [(4.4)](/filings/0001628280-25-051342.md) | [(6.7) d](/filings/0001628280-26-022057.md) | [(8.2)](/filings/0001628280-26-048455.md) | [(6.2)](/filings/0001628280-26-056741.md) |
| Diluted EPS | $ per share | [(0.34)](/filings/0001628280-24-046829.md) | not reported | [(0.31)](/filings/0001628280-25-025081.md) | [(0.07)](/filings/0001628280-25-039906.md) | [(0.40)](/filings/0001628280-25-051342.md) | not reported | [(0.24)](/filings/0001628280-26-048455.md) | [(0.13)](/filings/0001628280-26-056741.md) | [(0.15)](/filings/0001628280-25-051342.md) | not reported | [(0.25)](/filings/0001628280-26-048455.md) | [(0.19)](/filings/0001628280-26-056741.md) |
| Basic EPS | $ per share | [(0.34)](/filings/0001628280-24-046829.md) | not reported | [(0.31)](/filings/0001628280-25-025081.md) | [(0.07)](/filings/0001628280-25-039906.md) | [(0.40)](/filings/0001628280-25-051342.md) | not reported | [(0.24)](/filings/0001628280-26-048455.md) | [(0.13)](/filings/0001628280-26-056741.md) | [(0.15)](/filings/0001628280-25-051342.md) | not reported | [(0.25)](/filings/0001628280-26-048455.md) | [(0.19)](/filings/0001628280-26-056741.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [6.6](/filings/0001628280-24-046829.md) | [7.4](/filings/0001628280-25-015336.md) | [5.7](/filings/0001628280-25-025081.md) | [10.4](/filings/0001628280-25-039906.md) | [13.1](/filings/0001628280-25-051342.md) | [5.8](/filings/0001628280-26-048455.md) | [8.0](/filings/0001628280-26-048455.md) | [4.9](/filings/0001628280-26-056741.md) | [4.4](/filings/0001628280-26-048455.md) | [5.8](/filings/0001628280-26-056741.md) | [4.4](/filings/0001628280-26-048455.md) | [4.5](/filings/0001628280-26-056741.md) |
| Current assets | $m | [21.6](/filings/0001628280-23-038349.md) | [23.2](/filings/0001628280-25-015336.md) | [22.3](/filings/0001628280-24-022767.md) | [33.9](/filings/0001628280-24-036972.md) | [35.0](/filings/0001628280-24-046829.md) | [25.0](/filings/0001628280-26-022057.md) | [30.8](/filings/0001628280-25-025081.md) | [33.9](/filings/0001628280-25-039906.md) | [37.5](/filings/0001628280-25-051342.md) | [35.9](/filings/0001628280-26-056741.md) | [30.9](/filings/0001628280-26-048455.md) | [34.7](/filings/0001628280-26-056741.md) |
| Total assets | $m | [78.8](/filings/0001628280-23-038349.md) | [79.3](/filings/0001628280-25-015336.md) | [78.2](/filings/0001628280-24-022767.md) | [80.2](/filings/0001628280-24-036972.md) | [80.9](/filings/0001628280-24-046829.md) | [75.4](/filings/0001628280-26-022057.md) | [81.0](/filings/0001628280-25-025081.md) | [80.4](/filings/0001628280-25-039906.md) | [83.2](/filings/0001628280-25-051342.md) | [78.0](/filings/0001628280-26-056741.md) | [72.1](/filings/0001628280-26-048455.md) | [73.4](/filings/0001628280-26-056741.md) |
| Current liabilities | $m | [15.1](/filings/0001628280-23-038349.md) | [16.4](/filings/0001628280-25-015336.md) | [17.8](/filings/0001628280-24-022767.md) | [22.3](/filings/0001628280-24-036972.md) | [22.6](/filings/0001628280-24-046829.md) | [19.4](/filings/0001628280-26-022057.md) | [26.0](/filings/0001628280-25-025081.md) | [28.3](/filings/0001628280-25-039906.md) | [26.6](/filings/0001628280-25-051342.md) | [33.9](/filings/0001628280-26-056741.md) | [33.9](/filings/0001628280-26-048455.md) | [44.8](/filings/0001628280-26-056741.md) |
| Total liabilities | $m | [23.0](/filings/0001628280-23-038349.md) | [24.0](/filings/0001628280-25-015336.md) | [26.3](/filings/0001628280-24-022767.md) | [27.1](/filings/0001628280-24-036972.md) | [33.8](/filings/0001628280-24-046829.md) | [30.7](/filings/0001628280-26-022057.md) | [37.6](/filings/0001628280-25-025081.md) | [39.7](/filings/0001628280-25-039906.md) | [39.9](/filings/0001628280-25-051342.md) | [40.6](/filings/0001628280-26-056741.md) | [42.4](/filings/0001628280-26-048455.md) | [49.6](/filings/0001628280-26-056741.md) |
| Long-term debt | $m | not reported | [3.5](/filings/0001628280-24-046829.md) | [3.5](/filings/0001628280-24-022767.md) | [0.1](/filings/0001628280-24-036972.md) | [5.1](/filings/0001628280-24-046829.md) | [5.1](/filings/0001628280-25-051342.md) | [5.1](/filings/0001628280-25-025081.md) | [5.1](/filings/0001628280-25-039906.md) | [5.1](/filings/0001628280-25-051342.md) | [0.1](/filings/0001628280-26-056741.md) | [2.1](/filings/0001628280-26-048455.md) | [0.1](/filings/0001628280-26-056741.md) |
| Current portion of debt | $m | [0.3](/filings/0001628280-23-038349.md) | [0.4](/filings/0001628280-25-015336.md) | [0.2](/filings/0001628280-24-022767.md) | [3.5](/filings/0001628280-24-036972.md) | [3.7](/filings/0001628280-24-046829.md) | [4.4](/filings/0001628280-26-022057.md) | [4.2](/filings/0001628280-25-025081.md) | [0.4](/filings/0001628280-25-039906.md) | [0.5](/filings/0001628280-25-051342.md) | [5.5](/filings/0001628280-26-056741.md) | [5.3](/filings/0001628280-26-048455.md) | [8.2](/filings/0001628280-26-056741.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | [0.2](/filings/0001628280-25-051342.md) | [0.2](/filings/0001628280-25-025081.md) | [0.2](/filings/0001628280-25-039906.md) | [0.2](/filings/0001628280-25-051342.md) | not reported | not reported | not reported |
| Shareholders' equity | $m | [55.8](/filings/0001628280-24-046829.md) | [55.2](/filings/0001628280-26-022057.md) | [51.9](/filings/0001628280-25-039906.md) | [53.1](/filings/0001628280-25-051342.md) | [47.1](/filings/0001628280-25-051342.md) | [44.7](/filings/0001628280-26-056741.md) | [43.4](/filings/0001628280-26-056741.md) | [40.7](/filings/0001628280-26-056741.md) | [43.4](/filings/0001628280-25-051342.md) | [37.4](/filings/0001628280-26-056741.md) | [29.7](/filings/0001628280-26-056741.md) | [23.9](/filings/0001628280-26-056741.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(1.5) d](/filings/0001628280-24-046829.md) | [(4.4) d](/filings/0001628280-25-015336.md) | [(0.9)](/filings/0001628280-25-025081.md) | [(3.1) d](/filings/0001628280-25-039906.md) | [(0.3) d](/filings/0001628280-25-051342.md) | [(0.3) d](/filings/0001628280-26-022057.md) | [(5.7)](/filings/0001628280-26-048455.md) | [(5.9) d](/filings/0001628280-26-056741.md) | [3.0 d](/filings/0001628280-25-051342.md) | [(11.9) d](/filings/0001628280-26-022057.md) | [(0.1)](/filings/0001628280-26-048455.md) | [(4.5) d](/filings/0001628280-26-056741.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001628280-24-046829.md) | [0.0 d](/filings/0001628280-25-015336.md) | [0.0](/filings/0001628280-25-025081.md) | [0.0 d](/filings/0001628280-25-039906.md) | [0.0 d](/filings/0001628280-25-051342.md) | [0.0 d](/filings/0001628280-26-022057.md) | [0.0](/filings/0001628280-26-048455.md) | [0.0 d](/filings/0001628280-26-056741.md) | [0.0 d](/filings/0001628280-25-051342.md) | [0.0 d](/filings/0001628280-26-022057.md) | [0.0](/filings/0001628280-26-048455.md) | [0.0 d](/filings/0001628280-26-056741.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0001628280-24-011953.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [15.8](/filings/0001628280-23-038349.md) | [16.0](/filings/0001628280-24-022767.md) | [16.0](/filings/0001628280-24-036972.md) | [16.1](/filings/0001628280-24-046829.md) | [19.2](/filings/0001628280-25-025081.md) | [19.8](/filings/0001628280-25-039906.md) | [20.4](/filings/0001628280-25-051342.md) | [23.4](/filings/0001628280-26-048455.md) | [27.5](/filings/0001628280-26-056741.md) | [29.6](/filings/0001628280-25-051342.md) | [32.7](/filings/0001628280-26-048455.md) | [33.4](/filings/0001628280-26-056741.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 34,207,238 at 2026-08-12, from the cover of the [10-Q filed 2026-08-13](/filings/0001628280-26-056741.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.